Eurepa (Repaglinide)

Precautions of Eurepa (Repaglinide)

• Not for use in Type 1 diabetes or diabetic ketoacidosis
• Use cautiously in patients with liver impairment
• Avoid skipping meals while on this medication – it may cause low blood sugar
• Not recommended in pregnancy or breastfeeding unless advised by a physician

Uses of Eurepa (Repaglinide)

Eurepa is used for the treatment of:

• Type 2 Diabetes Mellitus (non-insulin-dependent diabetes)
• Managing post-meal blood sugar spikes
• Used alone or in combination with other oral antidiabetic agents

Side Effects of Eurepa (Repaglinide)

Common side effects include:

• Hypoglycemia (low blood sugar)
• Headache
• Joint or back pain
• Nausea or stomach discomfort

Serious (but rare) side effects:

• Liver enzyme elevation
• Blurred vision
• Allergic reactions (rash, itching, swelling)

FAQs of Eurepa (Repaglinide)

Q1. How does Eurepa work?
A: Eurepa stimulates the pancreas to release insulin, particularly around meal times, helping to lower post-meal blood glucose levels.

Q2. Can I take Eurepa if I skip a meal?
A: No. You should only take Eurepa before meals. Skip the dose if you're skipping a meal to avoid hypoglycemia.

Q3. Can Eurepa be taken with other diabetes medications?
A: Yes, it can be used with other oral antidiabetics like metformin, but only under medical supervision.

Q4. How fast does Eurepa act?
A: It acts quickly (within 30 minutes) and is short-acting, targeting meal-time sugar control.

Q5. Is Eurepa safe for elderly patients?
A: Yes, but careful monitoring is required due to the increased risk of hypoglycemia.

Interactions of Eurepa (Repaglinide)

Repaglinide may interact with:

• Gemfibrozil (increases risk of hypoglycemia)
• Ketoconazole, clopidogrel, and rifampin
• Other antidiabetic drugs (may require dose adjustment)
• Alcohol – may potentiate blood sugar-lowering effect
• Always inform your doctor about all medications and supplements you’re taking.